Skip to main content

Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial

Publication ,  Journal Article
Piccini, JP; Stevens, S; Lokhnygina, Y; Patel, M; Singer, D; Halperin, J; Hankey, G; Hacke, W; Becker, R; Nessel, C; Mahaffey, K; Fox, K ...
Published in: CIRCULATION
November 20, 2012

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 20, 2012

Volume

126

Issue

21

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., Stevens, S., Lokhnygina, Y., Patel, M., Singer, D., Halperin, J., … Breithardt, G. (2012). Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial. CIRCULATION, 126(21).
Piccini, Jonathan P., Susanna Stevens, Yuliya Lokhnygina, Manesh Patel, Daniel Singer, Jonathan Halperin, Graeme Hankey, et al. “Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial.” CIRCULATION 126, no. 21 (November 20, 2012).
Piccini JP, Stevens S, Lokhnygina Y, Patel M, Singer D, Halperin J, et al. Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial. CIRCULATION. 2012 Nov 20;126(21).
Piccini, Jonathan P., et al. “Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial.” CIRCULATION, vol. 126, no. 21, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2012.
Piccini JP, Stevens S, Lokhnygina Y, Patel M, Singer D, Halperin J, Hankey G, Hacke W, Becker R, Nessel C, Mahaffey K, Fox K, Califf R, Breithardt G. Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2012 Nov 20;126(21).

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 20, 2012

Volume

126

Issue

21

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology